Mar 03, 2020 / 03:00PM GMT
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
(technical difficulty) the 2 of you for being here with us today.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Yes, our pleasure.
Questions and Answers:
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystSo Agilent has long been one of our favorite larger cap tools names. We feel that the company has built to grow at a level that should be sustainably higher than the peer group. And there's tons of opportunities with the pristine balance sheet to not only use strong cash flow, but the existing balance sheet, be more aggressive in pursuing growth, both inorganically and organically. So one of our favorite names, one of the more exciting names in the group.
So I want to unpack that a little bit more in a few minutes. But much like we've done throughout the conference thus far, we want to just start by digging in a little bit on the COVID-19
Trustpilot
